ACLA Keeps the Pressure on CMS by Appealing Dismissal of PAMA Lawsuit
...
Already a member? Log in here
Labs Lose a Battle But May Win the War Over Market-Based Pricing
In its crusade to get CMS to fix its warped Protecting Access to Medicare Act of 2014 (PAMA) market-based Medicare Part B pricing scheme, the lab industry lost a battle but may still end up winning the war. Here’s a rundown of the rollercoaster PAMA developments and...MedPAC Explores Simplified PAMA Reporting to Cut Burdens & Restore Lab Prices
...
Already a member? Log in here
MedPAC Explores Simplified PAMA Reporting to Cut Burdens & Restore Lab Prices
...
Already a member? Log in here
The FDA Drops a Bombshell: No More EUA Review of COVID-19 LDTs
...
Already a member? Log in here